Nateglinide and Eyelid oedema - a phase IV clinical study of FDA data

Summary:

Eyelid oedema is reported only by a few people who take Nateglinide.

The phase IV clinical study analyzes which people take Nateglinide and have Eyelid oedema. It is created by eHealthMe based on reports of 1,654 people who have side effects while taking Nateglinide from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 12, 2023

1,654 people reported to have side effects when taking Nateglinide.
Among them, 2 people (0.12%) have Eyelid oedema.

What is Nateglinide?

Nateglinide has active ingredients of nateglinide. It is often used in type 2 diabetes. eHealthMe is studying from 1,668 Nateglinide users for its effectiveness, alternative drugs and more.

What is Eyelid oedema?

Eyelid oedema (eyelids are swollen and contain excessive fluid) is found to be associated with 1,966 drugs and 1,235 conditions by eHealthMe.

Number of Nateglinide and Eyelid oedema reports submitted per year:

Gender of people who have Eyelid oedema when taking Nateglinide *:

female: 100 %
male: 0.0 %

Age of people who have Eyelid oedema when taking Nateglinide *:

Common drugs people take besides Nateglinide *:

Common side effects people have besides Eyelid oedema *:

White Blood Cell Count Decreased: 1 person, 50.00%
Tooth Abscess (pus formation in tooth): 1 person, 50.00%
Acute Myocardial Infarction (acute heart attack): 1 person, 50.00%
Back Pain: 1 person, 50.00%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 1 person, 50.00%
Blood Creatinine Increased: 1 person, 50.00%
Breathing - Slowed Or Stopped: 1 person, 50.00%
Electrocardiogram Abnormal: 1 person, 50.00%
Face Oedema (swelling of face): 1 person, 50.00%
Flatulence (flatus expelled through the anus): 1 person, 50.00%

Common conditions people have *:

Renal Cell Carcinoma (a kidney cancer): 1 person, 50.00%
Metastases To Bone (cancer spreads to bone): 1 person, 50.00%
Insomnia (sleeplessness): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nateglinide and have Eyelid oedema?

Check whether Eyelid oedema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Eyelid oedema and when was it recovered:

Eyelid oedema in Nateglinide

Expand to all the drugs that have ingredients of nateglinide:

Eyelid oedema and drugs with ingredients of nateglinide

Alternative drugs to, pros and cons of Nateglinide:

Nateglinide (1,668 reports)

Eyelid oedema treatments and more:

Eyelid oedema (14,809 reports)

COVID vaccines that are related to Eyelid oedema:

Common drugs associated with Eyelid oedema:

All the drugs that are associated with Eyelid oedema:

Eyelid oedema (1,966 drugs)

Common conditions associated with Eyelid oedema:

High blood pressure: 677 reports
Rheumatoid arthritis: 336 reports
Dry eyes: 317 reports
Glaucoma: 297 reports

All the conditions that are associated with Eyelid oedema:

Eyelid oedema (1,235 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nateglinide (the active ingredients of Nateglinide) and Nateglinide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.